Free Trial

Ascendis Pharma A/S (ASND) Stock Price, News & Analysis

Ascendis Pharma A/S logo
$176.15 +7.98 (+4.75%)
As of 10:28 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Ascendis Pharma A/S Stock (NASDAQ:ASND)

Key Stats

Today's Range
$168.17
$177.00
50-Day Range
$151.25
$179.10
52-Week Range
$111.09
$183.00
Volume
143,836 shs
Average Volume
501,735 shs
Market Capitalization
$10.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$220.67
Consensus Rating
Buy

Company Overview

Ascendis Pharma A/S Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

ASND MarketRank™: 

Ascendis Pharma A/S scored higher than 70% of companies evaluated by MarketBeat, and ranked 275th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ascendis Pharma A/S has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 15 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Ascendis Pharma A/S has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Ascendis Pharma A/S's stock forecast and price target.
  • Earnings Growth

    Earnings for Ascendis Pharma A/S are expected to grow in the coming year, from ($4.34) to $0.24 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ascendis Pharma A/S is -26.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ascendis Pharma A/S is -26.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Ascendis Pharma A/S's valuation and earnings.
  • Percentage of Shares Shorted

    7.33% of the float of Ascendis Pharma A/S has been sold short.
  • Short Interest Ratio / Days to Cover

    Ascendis Pharma A/S has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Ascendis Pharma A/S has recently decreased by 20.41%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Ascendis Pharma A/S does not currently pay a dividend.

  • Dividend Growth

    Ascendis Pharma A/S does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.33% of the float of Ascendis Pharma A/S has been sold short.
  • Short Interest Ratio / Days to Cover

    Ascendis Pharma A/S has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Ascendis Pharma A/S has recently decreased by 20.41%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Ascendis Pharma A/S has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Ascendis Pharma A/S this week, compared to 7 articles on an average week.
  • Search Interest

    13 people have searched for ASND on MarketBeat in the last 30 days. This is an increase of 63% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ascendis Pharma A/S insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    40.00% of the stock of Ascendis Pharma A/S is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Ascendis Pharma A/S's insider trading history.
Receive ASND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

ASND Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
ASND Ascendis Pharma A/S - Seeking Alpha
See More Headlines

ASND Stock Analysis - Frequently Asked Questions

Ascendis Pharma A/S's stock was trading at $137.67 on January 1st, 2025. Since then, ASND stock has increased by 22.2% and is now trading at $168.17.

Ascendis Pharma A/S (NASDAQ:ASND) released its quarterly earnings results on Thursday, May, 1st. The biotechnology company reported ($1.66) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.56) by $0.10. The biotechnology company had revenue of $123.97 million for the quarter, compared to analyst estimates of $98.56 million.
Read the conference call transcript
.

Ascendis Pharma A/S (ASND) raised $85 million in an initial public offering on Wednesday, January 28th 2015. The company issued 5,000,000 shares at a price of $16.00-$18.00 per share. BofA Merrill Lynch and Leerink Partners served as the underwriters for the IPO and Wells Fargo Securities was co-manager.

Shares of ASND stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ascendis Pharma A/S investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), Novo Nordisk A/S (NVO) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
5/01/2025
Today
7/09/2025
Next Earnings (Estimated)
9/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ASND
CIK
1612042
Employees
1,017
Year Founded
N/A

Price Target and Rating

High Price Target
$289.00
Low Price Target
$153.00
Potential Upside/Downside
+31.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
15 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$409.12 million
Pretax Margin
-92.10%

Debt

Sales & Book Value

Annual Sales
$393.54 million
Price / Cash Flow
N/A
Book Value
($1.88) per share
Price / Book
-89.45

Miscellaneous

Free Float
36,679,000
Market Cap
$10.28 billion
Optionable
Optionable
Beta
0.38

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:ASND) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners